Communication/Slowness9 Dec 2020 18:32
In for a penny, in for a pound. I think this is still a good bet, and I'm pretty certain the drug actually works. But Synairgen have been very inaccurate with their timings and assertions about *when* things would get done, and rarely keep investors posted with how things are going (for example, they said that they expected to start Phase 3 trials in the last quarter of this year. Are they going to meet this target? We should be in the know on these things, and the companies poor timeliness and communications does make me worry a bit.